𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases

✍ Scribed by Beston F. Nore; Leonardo Vargas; Abdalla J. Mohamed; Lars J. Brandén; Carl-Magnus Bäckesjö; Tahmina C. Islam; Pekka T. Mattsson; Kjell Hultenby; Birger Christensson; C. I. Edvard Smith


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
504 KB
Volume
30
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Bruton's tyrosine kinase (Btk) is a member of the Tec family of protein tyrosine kinases (PTK) characterized by an N-terminal pleckstrin homology domain (PH) thought to directly interact with phosphoinositides. We report here that wild-type (wt) and also a gain-of-function mutant of Btk are redistributed following a wide range of receptor-mediated stimuli through phosphatidylinositol 3-kinase (PI 3-K) activation. Employing chimeric Btk with green fluorescent protein in transient transfections resulted in Btk translocation to the cytoplasmic membrane of live cells through various forms of upstream PI 3-K activation. The redistribution was blocked by pharmacological and biological inhibitors of PI 3-K. A gain-of-function mutant of Btk was found to be a potent inducer of lamellipodia and/or membrane ruffle formation. In the presence of constitutively active forms of Rac1 and Cdc42, Btk is co-localized with actin in these regions. Formation of the membrane structures was blocked by the dominant negative form of N17-Rac1. Therefore, Btk forms a link between a vast number of cell surface receptors activating PI 3-K and certain members of the Rho-family of small GTPases. In the chicken B cell line, DT40, cells lacking Btk differed from wt cells in the actin pattern and showed decreased capacity to form aggregates, further suggesting that cytoskeletal regulation mediated by Btk may be of physiological relevance.


📜 SIMILAR VOLUMES


Stability and folding of the SH3 domain
✍ Chen, Ya-Juan; Lin, Shih-Chieh; Tzeng, Shiou-Ru; Patel, Himatkumar V.; Lyu, Ping 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Bruton's tyrosine kinase (BTK) plays an important role in B cell development. Deletion of C-terminal14 amino acids of the SH3 domain of BTK results in X-linked a g ammaglobulinemia ( X U ) , an inherited disease. We report here on the stability and folding of SH3 domain of BTK. Peptides correspondin

Thrombin-stimulated phosphatidylinositol
✍ Mohamed R. Sayed; Michael P. Sheid; Christiaan M. Stevens; Vincent Duronio 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

In this study, we investigated the activation of a new member of the focal adhesion kinase family of tyrosine kinases, the proline-rich tyrosine kinase, or PYK2, in platelets. We show that PYK2 is tyrosine phosphorylated and its activity is increased during early stages of platelet aggregation. This

SH3 domain of Bruton's tyrosine kinase c
✍ Himatkumar V. Patel; Shiou-Ru Tzeng; Chen-Yee Liao; Shi-Han Chen; Jya-Wei Cheng 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

X-linked agammaglobulinemia (XLA), an inherited disease, is caused by mutations in the Bruton's tyrosine kinase (BTK). The absence of functional BTK leads to failure of B-cell differentiation; this incapacitates antibody production in XLA patients, who suffer from recurrent, sometimes lethal, bacter

Modulation of phosphatidylinositol-3-kin
✍ Imtiaz Ahmad Siddiqui; Vaqar Mustafa Adhami; Farrukh Afaq; Nihal Ahmad; Hasan Mu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

## Abstract We have earlier shown that oral infusion of a polyphenolic fraction isolated from green tea, at a human achievable dose (equivalent to six cups of green tea per day), significantly inhibits prostate cancer (PCA) development and metastasis in __tr__ansgenic __a__denocarcinoma of __m__ous

Stimulation of glycogen synthesis by ins
✍ Víctor Sánchez-Margalet 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

In order to study the role of phosphatidylinositol-3-kinase (PI3K), PKB, FRAP, S6 kinase, and MAP kinase in insulin-stimulated glycogen synthesis, we used a specific inhibitor of PI3K, LY294002, the immunosuppressant inhibitor of FRAP, rapamycin, and the inhibitor of MAPK kinase (MEK)/MAPK, PD98059,